The Department of Health has announced today that it will launch a review of how new medicines are developed and adopted.
The Innovative Medicines and Medical Technology review, which will consider how to speed up access to new drugs, medical technology and diagnostic tools, is due to begin next year and is expected to report in the summer. The review will examine how the UK’s healthcare and regulatory systems should respond to advances in technology that have the potential to transform treatments being made available.
Matthew Norton, Head of Policy at Alzheimer’s Research UK, the UK’s leading dementia research charity, said:
“Alzheimer’s Research UK welcomes this review and we look forward to responding to the consultation in due course. Recent advances in technology could have a huge impact on the treatments of tomorrow: for dementia, we have seen great strides in brain scanning, genetics and stem cell research that hold real promise.
“As research continues to make progress, it’s vitally important that new medicines can be made available swiftly to the people who need them. Efforts to streamline the complex regulatory process could play an important part in helping deliver new drugs sooner, and continued investment in research is also vital for ensuring promising leads for new treatments are taken forward.”
Posted in Policy news